Talkspace Inc
NASDAQ:TALK
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.65
3.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Talkspace Inc
Research & Development
Talkspace Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Talkspace Inc
NASDAQ:TALK
|
Research & Development
-$17.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Talkspace Inc
Glance View
Talkspace, Inc. is the virtual behavioral healthcare company committed to making care more effective, accessible, and convenient. The company is headquartered in New York City, New York. The company went IPO on 2020-06-09. The firm provides individuals and licensed therapists, psychologists and psychiatrists with an online platform for one-on-one therapy delivered through messaging, audio and video. The firm through its platform provides psychotherapy and psychiatry services to individuals, employers and health plans through both business to consumer (B2C) and business to business (B2B) channels. In psychotherapy or talk therapy members work with a licensed therapist or counselor to treat specific mental health conditions like depression or anxiety, trauma and other human challenges, including by developing positive thinking and coping skills. In psychiatry, members receive personalized, expert care from a prescriber who specializes in mental healthcare and prescription management. The Company’s services include couples therapy, teen therapy, LGBTQ+ community therapy, and unlimited messaging therapy.
See Also
What is Talkspace Inc's Research & Development?
Research & Development
-17.6m
USD
Based on the financial report for Dec 31, 2023, Talkspace Inc's Research & Development amounts to -17.6m USD.
What is Talkspace Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-22%
Over the last year, the Research & Development growth was 19%. The average annual Research & Development growth rates for Talkspace Inc have been -22% over the past three years .
You don't have any saved screeners yet
